Scientific Publications
Our science is rooted in evidence-based, peer-reviewed research.
Read from our library.
Publications
Sohn, K. et al. Bifidobacterium longum subsp infantis (EVC001) is associatedwith reduced incidence of necrotizing enterocolitis stage ≥2 and bloody stools in premature babies
Tobias, J. et al.
Bifidobacterium longum subsp. infantis EVC001 Administration Is Associated With a Significant Reduction In Incidence of Necrotizing Enterocolitis In Very Low Birth Weight Infants
Barratt, M. J. et al.
Bifidobacterium infantis treatment promotes weight gain in Bangladeshi infants with severe acute malnutirion
Bajorek, S. et al.
B. infantis EVC001 Is Well-Tolerated and Improves Human Milk Oligosaccharide Utilization in Preterm Infants in the Neonatal Intensive Care Unit
Larke, J. A. et al.
Preterm Infant Fecal Microbiota and Metabolite Profiles Are Modulated in a Probiotic Specific Manner
Casaburi, G. et al.
Metabolic model of necrotizing enterocolitis in the premature newborn gut resulting from enteric dysbiosis
Lueschow, S. R. et al.
Bifidobacterium longum subspecies infantis Strain EVC001 Decreases Neonatal Murine Necrotizing Enterocolitis
Nguyen, M. et al.
Impact of Probiotic B. infantis EVC001 Feeding in Premature Infants on the Gut Microbiome, Nosocomially Acquired Antibiotic Resistance, and Enteric Inflammation
Casaburi, G. et al.
Metagenomic insights of the infant microbiome community structure and function across multiple sites in the United States
Duar, R. et al.
Comparative Genome Analysis of Bifidobacterium longum subsp. infantis Strains Reveals Variation in Human Milk Oligosaccharide Utilization Genes among Commercial Probiotics
Henrick, B. et al.
Colonization by B. infantis EVC001 modulates enteric inflammation in exclusively breastfed infants
Frese, S. A. et al.
Persistence of Supplemented Bifidobacterium longum subsp. infantis EVC001 in Breastfed Infants
O'Brien, C. E. et al.
Early probiotic supplementation with B. infantis in breastfed infants leads to persistent colonization at 1 year
Dimitratos, S. M. et al.
Symptomatic relief from at-home use of activated Bifidobacterium infants EVC001 probiotic in infants:
Duar, R. et al.
Reintroducing B. infants to the cesarean-born neonate: an ecologically sound alternative to "vaginal seeding"
Duar, R. et al.
Colonization resistance in the infant gut: the role of B. infantis in reducing pH and preventing pathogen growth
Duar, R. et al.
Integrating the ecosystem services framework to define dysbiosis in the breastfed infant gut: The role of B. infantis and human milk oligosaccharides
Casaburi, G. et al.
Early-life gut microbiome modulation reduces the abundance of antibiotic-resistant bacteria
Karav, S. et al.
Reduced colonic mucin degradation in breastfed infants colonized by Bifidobacterium longum subsp. infantis EVC001
Casaburi, G. and Frese, S.
Colonization of breastfed infants by Bifidobacterium longum subsp. infantis EVC001 reduces virulence gene abundance
Henrick, B. M. et al.
Elevated fecal pH indicates a profound change in the breastfed infant gut microbiome due to a reduction of Bifidobacterium over the past century
Smilowitz, J. et al.
Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial
Karav, S. et al.
N-glycans from human milk glycoproteins are selectively released by and infant gut symbiont in vivo
Featured News Coverage
Our breakthrough findings on B. infantis EVC001 and its impacts on infant health have been addressed in notable publications around the world.